Fact CheckerSign in

NCT07428824Recruiting

Effects Of Functional Action Observation With Auditory Cueing In Stroke Patients

Effects of Functional Action Observation Therapy With Rhythmic Auditory Cueing on Balance and Gait in Patients With Stroke

Source: ClinicalTrials.gov · Last updated 24 Feb 2026

Brief summary (registry, in English)

This study aims to determine the effects of functional action observation therapy with and without rhythmic auditory cueing on balance and gait in patients with stroke. A randomized clinical trial will be conducted at Ittefaq Hospital Trust, Lahore and Alara Healthcare Clinic. The sample size will be 40. The non-probability convenience sampling methodology will be used to select participants who match the inclusion criteria and the online randomization will be used to further randomize them.Participants will be divided into 2 groups, 20 patients in clinical group and 20 patients in experimental group. While the clinical group will receive traditional therapy, the experimental group will receive Funtional Action Observation Therapy with auditory cueing. For four weeks, the subjects underwent 30 minutes of FAO or general action observation (GAO) instruction five times a week. The outcome measures will include assessments of balance and gait using Berg Balance Scale and Functional Gait Assessment. Assessments will be conducted on patients both before and after the intervention to identify any notable variations in their gait and balance

Status (registry)
Recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
8 Dec 2025
Start date
5 Nov 2025
Primary completion date
12 Apr 2026
Lead sponsor
Riphah International University
Diseases
Stroke
NCT number
NCT07428824

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 5 Nov 2025 to the primary completion date, 12 Apr 2026
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • hospitalization in the previous three months

Other illness

  • a positive history of neoplasms, cardiovascular disease, respiratory disease clinically significant muscular-skeletal disease

Other

  • Subjects with MMSE score less than 25
  • uncorrected visual or auditory disturbances
  • Patients with aggressive behavioral alterations or emotional lability

Who the study is looking for

  • Age 40 to 60 years
  • Both male and female patients are included in the study
  • 6 months to 2 years since the onset of stroke
  • Ability to sit and stand up independently
  • Ability to walk more than 10 m, with or without an assistant device
  • No orthopedic impairments on both lower

Age in the registry: 40 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ittefaq Hospital (Trust), Lahore
Coordinator of this site? Confirm its status
LahorePakistanRecruiting
Alara Healthcare Clinic
Coordinator of this site? Confirm its status
LahorePakistanRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.